- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Institutional Culture and Sensitive Investigations
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
< Back to Bio
Alexander Kazam
View all
Alexander Kazam
News 15 results
Cases & Deals
March 31, 2025
King & Spalding Secures Victory for The American Clinical Laboratory Association Challenging a Final Rule Issued by the FDA
In the News · Source: Law360 and The AmLaw Litigation Daily
Press Release
December 10, 2024
King & Spalding Elects 37 New Partners and Five Counsel in Record Promotion Round
In the News · Source: The American Lawyer, Bloomberg Law, Le Monde du Droit, Law Middle East, Law360 Pulse, Legalcommunity MENA, The Oath, The Deal, The Texas Lawbook, ABF Journal, Global Arbitration Review, Global Legal Chronicle, Décideurs Magazine, Boursier, CFNEWS, Texas Lawyer, Houston Bar Association, Global Restructuring Review and Texas Bar Journal
December 10, 2024
K&S elects 37 new partners and promotes five counsel across 14 cities
Events 1 results
Conference
November 7, 2023
Pharmaceutical University 2023